Your browser doesn't support javascript.
loading
Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats.
Hickman, M A; Cox, S R; Mahabir, S; Miskell, C; Lin, J; Bunger, A; McCall, R B.
Affiliation
  • Hickman MA; Pfizer Animal Health, Discovery Research, Pfizer Inc, Kalamazoo, MI 49001, USA.
J Vet Pharmacol Ther ; 31(3): 220-9, 2008 Jun.
Article in En | MEDLINE | ID: mdl-18471143
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinuclidines / Vomiting / Motion Sickness / Neurokinin-1 Receptor Antagonists Type of study: Etiology_studies Limits: Animals Language: En Journal: J Vet Pharmacol Ther Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinuclidines / Vomiting / Motion Sickness / Neurokinin-1 Receptor Antagonists Type of study: Etiology_studies Limits: Animals Language: En Journal: J Vet Pharmacol Ther Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido